tirzepatide kidney pain (Zepbound) showed improved function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Positive Results for Tirzepatide in

This supplement should be stored in a cool, dry place, away from direct sunlight and out of reach of children

What used to be a $1 or $1.5 billion market space is now a $5 or $6 billion market space and it is growing very rapidly because more and more drugs are coming out into the market, which are peptides. Saharsh Davuluri, Vice-Chairman & MD, Neuland Laboratories | Q1 FY26 Its not just about the weight loss drugs that have been commercialized, but its also about the next gens, not just from the large companies, but other companies as well

As of 2026, Wegovy (semaglutide) is a mature, mainstream option on the UK market for adults who need help to lose weight alongside diet, exercise, and behavioural support

For many patients, the weekly schedule is one of the biggest advantages